The global CBD edibles industry is on track for major expansion, with market value expected to climb from $15.1 billion in 2025 to $38 billion by 2034, according to a new forecast.

That represents a compound annual growth rate of 10.8% over the nine-year period, driven largely by consumer demand for wellness products, expanding legalization, and increasing awareness of CBD’s benefits.

In 2024, the market was valued at $13.63 billion, with North America holding the largest share at 40%. Analysts project Asia Pacific to see the fastest growth through 2034 as hemp cultivation expands and e-commerce access widens. By product type, gummies dominated with 58% of the market last year, while supplements are expected to grow most rapidly in the coming years.

Hemp-derived edibles accounted for 70% of sales in 2024 due to their legal status and low THC content, but marijuana-derived products are projected to grow at a significant pace as regulations evolve. The organic segment held 58% of the market last year, though conventionally produced products are set to expand quickly because of lower costs.

Health and wellness applications accounted for 65% of sales in 2024, reflecting consumer interest in natural remedies for pain, anxiety, and sleep disorders. At the same time, recreational use is forecast to grow steadily as more countries and U.S. states legalize marijuana.

Industry players continue to innovate in response to demand. Recent advances in nanotechnology have shortened onset times for edibles, while improved extraction and formulation methods have increased consistency and bioavailability. Companies like Charlotte’s Web, CV Sciences, and Wana Brands remain major players, alongside newer entrants focused on fast-acting or specialty formulations.

While regulatory challenges remain—particularly in regions like the European Union and China—analysts see diversification of products and the growing acceptance of CBD as key drivers that will keep the market on a sharp upward trajectory through the next decade.